Profile
Jim McPherson served as President & Chief Executive Officer at Phixen SAS from 2023 to 2024.
He also held the same position at Cenexi Services SAS during the same period.
Prior to these roles, he worked as a Principal at GlaxoSmithKline Pharmaceuticals SA (Belgium) and as Vice President-Supply Chain at Xellia Pharmaceuticals ApS.
Mr. McPherson obtained his undergraduate degree and an MBA from the University of Glasgow.
He also completed an undergraduate degree at Napier University.
Former positions of Jim McPherson
| Companies | Position | End |
|---|---|---|
Cenexi Services SAS
 Cenexi Services SAS Pharmaceuticals: MajorHealth Technology Part of Phinex SAS, Cenexi Services SAS is a French company that provides contract development and manufacturing services for pharmaceutical companies. The company is based in Fontenay-sous-Bois, France. The company was founded in 2010. Alain Kirchmeyer has been the CEO of the company since 2024. | Chief Executive Officer | 31/03/2024 |
Phixen SAS
 Phixen SAS Financial ConglomeratesFinance Part of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Phixen SAS is an investment holding French company. The company is based in Fontenay-sous-Bois, France. Founded in 2015. Phixen was acquired by Gland Pharma International Pte Ltd (Singapore) on April 27, 2023 for $124.77 million. | Chief Executive Officer | 26/02/2024 |
Xellia Pharmaceuticals ApS
 Xellia Pharmaceuticals ApS Medical/Nursing ServicesHealth Services Xellia Pharmaceuticals ApS manufactures pharmaceutical products. Its products include pharmaceutical ingredients, finished dosage forms and novel anti infective pipeline. The company was founded in 1959 and is headquartered in Copenhagen, Denmark. | Corporate Officer/Principal | - |
GlaxoSmithKline Pharmaceuticals SA (Belgium)
 GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology GlaxoSmithKline Pharmaceuticals SA develops and manufactures pharmaceuticals and vaccines. The company is headquartered in Wavre, Belgium. | Corporate Officer/Principal | - |
Training of Jim McPherson
| University of Glasgow | Masters Business Admin |
| Napier University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
GlaxoSmithKline Pharmaceuticals SA (Belgium)
GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology GlaxoSmithKline Pharmaceuticals SA develops and manufactures pharmaceuticals and vaccines. The company is headquartered in Wavre, Belgium. | Health Technology |
Xellia Pharmaceuticals ApS
Xellia Pharmaceuticals ApS Medical/Nursing ServicesHealth Services Xellia Pharmaceuticals ApS manufactures pharmaceutical products. Its products include pharmaceutical ingredients, finished dosage forms and novel anti infective pipeline. The company was founded in 1959 and is headquartered in Copenhagen, Denmark. | Health Services |
Phixen SAS
Phixen SAS Financial ConglomeratesFinance Part of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Phixen SAS is an investment holding French company. The company is based in Fontenay-sous-Bois, France. Founded in 2015. Phixen was acquired by Gland Pharma International Pte Ltd (Singapore) on April 27, 2023 for $124.77 million. | Finance |
Cenexi Services SAS
Cenexi Services SAS Pharmaceuticals: MajorHealth Technology Part of Phinex SAS, Cenexi Services SAS is a French company that provides contract development and manufacturing services for pharmaceutical companies. The company is based in Fontenay-sous-Bois, France. The company was founded in 2010. Alain Kirchmeyer has been the CEO of the company since 2024. | Health Technology |
- Stock Market
- Insiders
- Jim McPherson
